Catalyst Wire Dossier Catalyst Wire Dossier

Enhancor System

· Pulnovo Medical, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Enhancor System, covering 2026-03-12 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease [NA]

See pricing